NCT00776217View on ClinicalTrials.gov

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2006

Study Completion Date

September 30, 2006

Conditions
Healthy
Interventions
DRUG

loratadine 10 mg orally disintegrating tablets

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00776217 - Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions | Biotech Hunter | Biotech Hunter